Premium
Option Care Health Inc (OPCH)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Mr. Collin G. SmyserGeneral Counsel & Corporate Secretary | -360,00 | 7,51k | Derivative Exercise and Sale | 20,86 | 46,35k | - |
| 2026-05-19 | Mr. Collin G. SmyserGeneral Counsel & Corporate Secretary | 452,00 | 0,00 | Derivative Exercise and Retained Stock | - | 46,35k | 0,98% |
| 2026-05-07 | Mr. Timothy P. SullivanIndependent Director | 24,15k | 499,67k | Achat | 20,69 | 73,38k | 49,06% |
| 2026-05-04 | Mr. Harry M. Jansen KraemerIndependent Non Executive Chairman of the Board | 36,61k | 783,77k | Achat | 21,41 | 421,22k | 9,52% |
| 2026-05-04 | Ms. Meenal Anil SethnaExec. VP & CFO | 16,23k | 327,07k | Achat | 20,16 | 98,34k | 19,76% |
| 2026-05-04 | Mr. John Charles RademacherCEO, President & Director | 12,50k | 264,71k | Achat | 21,18 | 695,15k | 1,83% |
| 2026-04-22 | Dr. Femi AdewunmiChief Medical Officer | -1,40k | 39,62k | Sale to Issuer | 28,38 | 5,59k | -19,99% |
| 2026-02-27 | Mr. R. Carter PateIndependent Director | -30,29k | 970,62k | Vente | 32,05 | 11,62k | -72,27% |
| 2026-02-27 | Mr. Michael BavaroChief HR & Chief Diversity Officer | -6,00k | 198,00k | Vente | 33,00 | 14,21k | -29,69% |
| 2026-02-24 | Mr. Luke WhitworthCOO | -4,61k | 155,72k | Sale to Issuer | 33,82 | 169,59k | -2,64% |
| 2026-02-24 | Mr. Christopher L. GrashoffInitié | -1,98k | 66,95k | Sale to Issuer | 33,82 | 44,09k | -4,30% |
| 2026-02-24 | Mr. Collin G. SmyserGeneral Counsel & Corporate Secretary | -2,21k | 74,73k | Sale to Issuer | 33,82 | 45,90k | -4,59% |
| 2026-02-24 | Dr. Femi AdewunmiChief Medical Officer | -1,63k | 55,02k | Sale to Issuer | 33,82 | 3,70k | -30,57% |
| 2026-02-24 | Mr. John Charles RademacherCEO, President & Director | -11,05k | 373,66k | Sale to Issuer | 33,82 | 682,65k | -1,59% |
| 2026-02-24 | Ms. Nicole MaggioSenior VP, Controller & Principal Accounting Officer | -975,00 | 32,97k | Sale to Issuer | 33,82 | 28,49k | -3,31% |
| 2026-02-24 | Mr. Michael BavaroChief HR & Chief Diversity Officer | -1,35k | 45,79k | Sale to Issuer | 33,82 | 20,21k | -6,28% |
| 2026-02-20 | Mr. Michael BavaroChief HR & Chief Diversity Officer | -13,40k | 478,21k | Sale to Issuer | 35,69 | 16,73k | -44,47% |
| 2026-02-20 | Mr. Christopher L. GrashoffInitié | -2,49k | 88,73k | Sale to Issuer | 35,69 | 14,92k | -14,28% |
| 2026-02-20 | Ms. Nicole MaggioSenior VP, Controller & Principal Accounting Officer | -991,00 | 35,37k | Sale to Issuer | 35,69 | 10,18k | -8,87% |
| 2026-02-20 | Mr. Luke WhitworthCOO | -28,04k | 1,00M | Sale to Issuer | 35,69 | 100,54k | -21,81% |
| 2026-02-21 | Mr. John Charles RademacherCEO, President & Director | -11,09k | 395,70k | Derivative Exercise and Sale | 35,69 | 504,18k | - |
| 2026-02-20 | Mr. John Charles RademacherCEO, President & Director | -137,36k | 4,90M | Sale to Issuer | 35,69 | 504,18k | -21,41% |
| 2026-02-20 | Mr. Collin G. SmyserGeneral Counsel & Corporate Secretary | -17,45k | 622,61k | Sale to Issuer | 35,69 | 43,12k | -28,80% |
| 2026-02-17 | Mr. Luke WhitworthCOO | -508,00 | 17,90k | Sale to Issuer | 35,24 | 65,68k | -0,77% |
| 2026-02-17 | Mr. Christopher L. GrashoffInitié | -259,00 | 9,13k | Sale to Issuer | 35,24 | 12,34k | -2,06% |
| 2026-02-17 | Mr. Michael BavaroChief HR & Chief Diversity Officer | -551,00 | 19,42k | Sale to Issuer | 35,24 | 558,00 | -49,68% |
| 2026-02-18 | Ms. Nicole MaggioSenior VP, Controller & Principal Accounting Officer | -247,00 | 8,70k | Sale to Issuer | 35,24 | 9,18k | -2,62% |
| 2025-11-03 | Mr. Harry M. Jansen KraemerIndependent Non Executive Chairman of the Board | 38,00k | 987,39k | Achat | 25,98 | 384,61k | 10,96% |
| 2025-09-09 | Mr. Norman L. WrightIndependent Director | 3,41k | 99,98k | Achat | 29,31 | 6,92k | 97,29% |
| 2025-08-20 | Mr. Harry M. Jansen KraemerIndependent Non Executive Chairman of the Board | 36,00k | 977,28k | Achat | 27,15 | 346,61k | 11,59% |
| 2025-08-20 | Mr. R. Carter PateIndependent Director | 750,00 | 20,39k | Achat | 27,19 | 41,91k | 1,82% |
| 2025-08-21 | Mr. Timothy P. SullivanIndependent Director | 20,00k | 550,20k | Achat | 27,51 | 49,23k | 68,43% |
| 2025-08-21 | Mr. David W. GoldingInitié | 1 000,00 | 27,63k | Achat | 27,63 | 116,53k | 0,87% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
